nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.113	0.251	CbGbCtD
Rotigotine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0901	0.2	CbGbCtD
Rotigotine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0591	0.131	CbGbCtD
Rotigotine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0549	0.122	CbGbCtD
Rotigotine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0441	0.098	CbGbCtD
Rotigotine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0252	0.0561	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0248	0.0551	CbGbCtD
Rotigotine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0231	0.0514	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0158	0.035	CbGbCtD
Rotigotine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000713	0.00133	CcSEcCtD
Rotigotine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000711	0.00132	CcSEcCtD
Rotigotine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000709	0.00132	CcSEcCtD
Rotigotine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000703	0.00131	CcSEcCtD
Rotigotine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000702	0.0013	CcSEcCtD
Rotigotine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000702	0.0013	CcSEcCtD
Rotigotine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.0007	0.0013	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000697	0.0013	CcSEcCtD
Rotigotine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000695	0.00129	CcSEcCtD
Rotigotine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000695	0.00129	CcSEcCtD
Rotigotine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000694	0.00129	CcSEcCtD
Rotigotine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000693	0.00129	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000693	0.00129	CcSEcCtD
Rotigotine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.00128	CcSEcCtD
Rotigotine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000689	0.00128	CcSEcCtD
Rotigotine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000689	0.00128	CcSEcCtD
Rotigotine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000688	0.00128	CcSEcCtD
Rotigotine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00128	CcSEcCtD
Rotigotine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000683	0.00127	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000681	0.00127	CcSEcCtD
Rotigotine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000681	0.00127	CcSEcCtD
Rotigotine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000681	0.00127	CcSEcCtD
Rotigotine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000678	0.00126	CcSEcCtD
Rotigotine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000675	0.00126	CcSEcCtD
Rotigotine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000675	0.00126	CcSEcCtD
Rotigotine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00124	CcSEcCtD
Rotigotine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000668	0.00124	CcSEcCtD
Rotigotine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000664	0.00123	CcSEcCtD
Rotigotine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.00123	CcSEcCtD
Rotigotine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000662	0.00123	CcSEcCtD
Rotigotine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000662	0.00123	CcSEcCtD
Rotigotine—Rash—Topotecan—peripheral nervous system neoplasm	0.000662	0.00123	CcSEcCtD
Rotigotine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000661	0.00123	CcSEcCtD
Rotigotine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000661	0.00123	CcSEcCtD
Rotigotine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00066	0.00123	CcSEcCtD
Rotigotine—Cough—Etoposide—peripheral nervous system neoplasm	0.000659	0.00123	CcSEcCtD
Rotigotine—Headache—Topotecan—peripheral nervous system neoplasm	0.000658	0.00122	CcSEcCtD
Rotigotine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000657	0.00122	CcSEcCtD
Rotigotine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000657	0.00122	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000657	0.00122	CcSEcCtD
Rotigotine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000656	0.00122	CcSEcCtD
Rotigotine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000656	0.00122	CcSEcCtD
Rotigotine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000656	0.00122	CcSEcCtD
Rotigotine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000654	0.00122	CcSEcCtD
Rotigotine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000653	0.00121	CcSEcCtD
Rotigotine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000652	0.00121	CcSEcCtD
Rotigotine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000652	0.00121	CcSEcCtD
Rotigotine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000652	0.00121	CcSEcCtD
Rotigotine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00065	0.00121	CcSEcCtD
Rotigotine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00065	0.00121	CcSEcCtD
Rotigotine—Pain—Vincristine—peripheral nervous system neoplasm	0.00065	0.00121	CcSEcCtD
Rotigotine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00065	0.00121	CcSEcCtD
Rotigotine—Rash—Melphalan—peripheral nervous system neoplasm	0.000648	0.00121	CcSEcCtD
Rotigotine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000648	0.0012	CcSEcCtD
Rotigotine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000642	0.00119	CcSEcCtD
Rotigotine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000641	0.00119	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000638	0.00119	CcSEcCtD
Rotigotine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000635	0.00118	CcSEcCtD
Rotigotine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000635	0.00118	CcSEcCtD
Rotigotine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000628	0.00117	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000628	0.00117	CcSEcCtD
Rotigotine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000627	0.00117	CcSEcCtD
Rotigotine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000627	0.00117	CcSEcCtD
Rotigotine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000624	0.00116	CcSEcCtD
Rotigotine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000621	0.00116	CcSEcCtD
Rotigotine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000619	0.00115	CcSEcCtD
Rotigotine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000619	0.00115	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000613	0.00114	CcSEcCtD
Rotigotine—Infection—Etoposide—peripheral nervous system neoplasm	0.000612	0.00114	CcSEcCtD
Rotigotine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000611	0.00114	CcSEcCtD
Rotigotine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000611	0.00114	CcSEcCtD
Rotigotine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000604	0.00112	CcSEcCtD
Rotigotine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000598	0.00111	CcSEcCtD
Rotigotine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000596	0.00111	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.0011	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.00109	CcSEcCtD
Rotigotine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000587	0.00109	CcSEcCtD
Rotigotine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000585	0.00109	CcSEcCtD
Rotigotine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000582	0.00108	CcSEcCtD
Rotigotine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.00108	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.00108	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000581	0.00108	CcSEcCtD
Rotigotine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000576	0.00107	CcSEcCtD
Rotigotine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000575	0.00107	CcSEcCtD
Rotigotine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000566	0.00105	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000564	0.00105	CcSEcCtD
Rotigotine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00056	0.00104	CcSEcCtD
Rotigotine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.00104	CcSEcCtD
Rotigotine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000554	0.00103	CcSEcCtD
Rotigotine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000553	0.00103	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000553	0.00103	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000549	0.00102	CcSEcCtD
Rotigotine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000548	0.00102	CcSEcCtD
Rotigotine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000546	0.00101	CcSEcCtD
Rotigotine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000542	0.00101	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000542	0.00101	CcSEcCtD
Rotigotine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000541	0.00101	CcSEcCtD
Rotigotine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.001	CcSEcCtD
Rotigotine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000537	0.000998	CcSEcCtD
Rotigotine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000536	0.000996	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000532	0.000989	CcSEcCtD
Rotigotine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000531	0.000988	CcSEcCtD
Rotigotine—Pain—Etoposide—peripheral nervous system neoplasm	0.000527	0.00098	CcSEcCtD
Rotigotine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000527	0.00098	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000971	CcSEcCtD
Rotigotine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.000971	CcSEcCtD
Rotigotine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00052	0.000968	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.000951	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000945	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000945	CcSEcCtD
Rotigotine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000508	0.000944	CcSEcCtD
Rotigotine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000506	0.00094	CcSEcCtD
Rotigotine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000503	0.000935	CcSEcCtD
Rotigotine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000502	0.000933	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000932	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000932	CcSEcCtD
Rotigotine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000498	0.000926	CcSEcCtD
Rotigotine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000497	0.000925	CcSEcCtD
Rotigotine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000495	0.000921	CcSEcCtD
Rotigotine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000494	0.00092	CcSEcCtD
Rotigotine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000489	0.00091	CcSEcCtD
Rotigotine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000484	0.000899	CcSEcCtD
Rotigotine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000483	0.000897	CcSEcCtD
Rotigotine—Rash—Vincristine—peripheral nervous system neoplasm	0.00048	0.000892	CcSEcCtD
Rotigotine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000479	0.000891	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000891	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000888	CcSEcCtD
Rotigotine—Headache—Vincristine—peripheral nervous system neoplasm	0.000476	0.000886	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000874	CcSEcCtD
Rotigotine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.000872	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000871	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00046	0.000856	CcSEcCtD
Rotigotine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000454	0.000844	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000843	CcSEcCtD
Rotigotine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000452	0.00084	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000824	CcSEcCtD
Rotigotine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000442	0.000822	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000822	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00082	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000817	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000815	CcSEcCtD
Rotigotine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000436	0.000811	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000806	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000428	0.000795	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000792	CcSEcCtD
Rotigotine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000424	0.000789	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000424	0.000788	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000787	CcSEcCtD
Rotigotine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000787	CcSEcCtD
Rotigotine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000422	0.000784	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.00078	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000759	CcSEcCtD
Rotigotine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000407	0.000758	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000757	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000756	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000754	CcSEcCtD
Rotigotine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000399	0.000743	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000733	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00073	CcSEcCtD
Rotigotine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000392	0.000729	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000728	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000728	CcSEcCtD
Rotigotine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000723	CcSEcCtD
Rotigotine—Rash—Etoposide—peripheral nervous system neoplasm	0.000388	0.000722	CcSEcCtD
Rotigotine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000388	0.000722	CcSEcCtD
Rotigotine—Headache—Etoposide—peripheral nervous system neoplasm	0.000386	0.000718	CcSEcCtD
Rotigotine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000382	0.00071	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000707	CcSEcCtD
Rotigotine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000706	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.0007	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000692	CcSEcCtD
Rotigotine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000687	CcSEcCtD
Rotigotine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000366	0.000681	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000679	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000676	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00067	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000669	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000665	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000662	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000657	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000655	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000654	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000653	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000648	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.00064	CcSEcCtD
Rotigotine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000638	CcSEcCtD
Rotigotine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000635	CcSEcCtD
Rotigotine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000632	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00063	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000629	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000624	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000621	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00062	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000616	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000612	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000612	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000606	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000323	0.0006	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000599	CcSEcCtD
Rotigotine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00059	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000585	CcSEcCtD
Rotigotine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000585	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000583	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000581	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000577	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000577	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000574	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000571	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000566	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000565	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000558	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000555	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000554	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000554	CcSEcCtD
Rotigotine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000549	CcSEcCtD
Rotigotine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000549	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000541	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000537	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000534	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000529	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000528	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000523	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000517	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000513	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000512	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00051	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000508	CcSEcCtD
Rotigotine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000508	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.00049	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000473	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000472	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000461	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000454	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000439	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000438	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000426	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000425	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00042	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000408	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000407	CcSEcCtD
Rotigotine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000405	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000405	CcSEcCtD
Rotigotine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000402	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000393	CcSEcCtD
Rotigotine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000381	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000378	CcSEcCtD
Rotigotine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000375	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000374	CcSEcCtD
Rotigotine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000372	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000353	CcSEcCtD
Rotigotine—DRD1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.89e-05	0.0023	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.86e-05	0.00227	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.85e-05	0.00227	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	2.85e-05	0.00227	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.84e-05	0.00226	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.84e-05	0.00226	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.84e-05	0.00226	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.82e-05	0.00224	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.81e-05	0.00224	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.8e-05	0.00223	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.74e-05	0.00218	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	2.73e-05	0.00217	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.71e-05	0.00215	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.64e-05	0.0021	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—KNG1—peripheral nervous system neoplasm	2.63e-05	0.00209	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.6e-05	0.00207	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.57e-05	0.00205	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.55e-05	0.00203	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.55e-05	0.00203	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.55e-05	0.00203	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.54e-05	0.00202	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.49e-05	0.00198	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.48e-05	0.00198	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.47e-05	0.00197	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.46e-05	0.00196	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.46e-05	0.00195	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.4e-05	0.00191	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.38e-05	0.00189	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.37e-05	0.00189	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.35e-05	0.00187	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.34e-05	0.00187	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—GNAS—peripheral nervous system neoplasm	2.3e-05	0.00183	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.27e-05	0.00181	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.23e-05	0.00177	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.23e-05	0.00177	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.2e-05	0.00175	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—HGF—peripheral nervous system neoplasm	2.19e-05	0.00174	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.18e-05	0.00174	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.16e-05	0.00172	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.14e-05	0.0017	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.11e-05	0.00168	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.07e-05	0.00165	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.03e-05	0.00162	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	2e-05	0.0016	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.99e-05	0.00158	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.98e-05	0.00158	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.92e-05	0.00153	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.92e-05	0.00152	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.9e-05	0.00151	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.88e-05	0.0015	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.87e-05	0.00149	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.87e-05	0.00149	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.84e-05	0.00147	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.84e-05	0.00146	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.81e-05	0.00144	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.76e-05	0.0014	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.73e-05	0.00138	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.73e-05	0.00137	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.7e-05	0.00136	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.69e-05	0.00135	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.69e-05	0.00134	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.68e-05	0.00134	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.67e-05	0.00133	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.67e-05	0.00133	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.66e-05	0.00132	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.65e-05	0.00131	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.63e-05	0.0013	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.62e-05	0.00129	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.61e-05	0.00128	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.61e-05	0.00128	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.6e-05	0.00128	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.6e-05	0.00127	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.57e-05	0.00125	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.56e-05	0.00124	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.55e-05	0.00123	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.54e-05	0.00122	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.51e-05	0.0012	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.51e-05	0.0012	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.5e-05	0.0012	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.48e-05	0.00118	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.46e-05	0.00116	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.46e-05	0.00116	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.45e-05	0.00116	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.45e-05	0.00116	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.44e-05	0.00114	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.41e-05	0.00112	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.4e-05	0.00112	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.39e-05	0.0011	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.37e-05	0.00109	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.34e-05	0.00107	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.32e-05	0.00105	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.32e-05	0.00105	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.3e-05	0.00104	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.3e-05	0.00103	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.28e-05	0.00102	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.27e-05	0.00101	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.27e-05	0.00101	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.23e-05	0.00098	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000959	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.18e-05	0.000936	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.17e-05	0.000934	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.17e-05	0.000931	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.15e-05	0.000919	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.14e-05	0.00091	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.14e-05	0.000909	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.12e-05	0.000895	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.12e-05	0.00089	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.11e-05	0.000885	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.08e-05	0.000862	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.06e-05	0.000844	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.06e-05	0.000843	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.04e-05	0.00083	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.00082	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.02e-05	0.000809	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.01e-05	0.000801	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1e-05	0.000797	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	9.94e-06	0.000791	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.87e-06	0.000786	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.72e-06	0.000774	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	9.61e-06	0.000765	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.54e-06	0.000759	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	9.53e-06	0.000758	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.41e-06	0.000749	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.32e-06	0.000742	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	9.17e-06	0.00073	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.17e-06	0.00073	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.15e-06	0.000729	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.91e-06	0.00071	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.85e-06	0.000705	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.83e-06	0.000703	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.75e-06	0.000697	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.63e-06	0.000687	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.61e-06	0.000685	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.5e-06	0.000676	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.2e-06	0.000653	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.8e-06	0.000621	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.77e-06	0.000619	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.67e-06	0.000611	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.56e-06	0.000601	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.52e-06	0.000599	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.35e-06	0.000585	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	7.35e-06	0.000585	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.23e-06	0.000576	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.2e-06	0.000573	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	7.11e-06	0.000566	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.08e-06	0.000563	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	7.03e-06	0.00056	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.88e-06	0.000547	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.82e-06	0.000543	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.76e-06	0.000538	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.63e-06	0.000528	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.61e-06	0.000526	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.57e-06	0.000523	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	6.21e-06	0.000494	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.19e-06	0.000493	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.11e-06	0.000486	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.08e-06	0.000484	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.02e-06	0.000479	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.02e-06	0.000479	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	6e-06	0.000478	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6e-06	0.000478	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.73e-06	0.000456	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.65e-06	0.000449	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.51e-06	0.000439	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.5e-06	0.000438	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.42e-06	0.000431	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.34e-06	0.000425	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.32e-06	0.000424	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.23e-06	0.000416	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.13e-06	0.000408	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.09e-06	0.000405	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.03e-06	0.0004	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.89e-06	0.000389	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.85e-06	0.000386	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.85e-06	0.000386	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.81e-06	0.000383	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.78e-06	0.000381	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.74e-06	0.000378	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.67e-06	0.000372	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.65e-06	0.00037	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.61e-06	0.000367	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.59e-06	0.000366	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.53e-06	0.000361	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.52e-06	0.00036	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.47e-06	0.000356	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.44e-06	0.000354	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.4e-06	0.000351	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.36e-06	0.000347	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.34e-06	0.000346	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.3e-06	0.000343	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.28e-06	0.000341	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.21e-06	0.000335	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.13e-06	0.000329	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.06e-06	0.000323	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.03e-06	0.000321	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.03e-06	0.000321	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4e-06	0.000318	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.95e-06	0.000314	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.93e-06	0.000313	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.92e-06	0.000312	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.9e-06	0.000311	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.89e-06	0.00031	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.89e-06	0.000309	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.83e-06	0.000305	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.79e-06	0.000301	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.78e-06	0.000301	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.75e-06	0.000299	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.75e-06	0.000298	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.69e-06	0.000294	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.66e-06	0.000291	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.63e-06	0.000289	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.61e-06	0.000287	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.56e-06	0.000284	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.55e-06	0.000283	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.44e-06	0.000274	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.42e-06	0.000272	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.41e-06	0.000271	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.36e-06	0.000268	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.32e-06	0.000265	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.29e-06	0.000262	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.26e-06	0.000259	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.14e-06	0.00025	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.11e-06	0.000247	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.03e-06	0.000242	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.02e-06	0.00024	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.01e-06	0.00024	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.97e-06	0.000237	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.96e-06	0.000235	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.93e-06	0.000233	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.8e-06	0.000223	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.76e-06	0.00022	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.76e-06	0.00022	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.68e-06	0.000213	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.64e-06	0.00021	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.62e-06	0.000209	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.57e-06	0.000205	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.49e-06	0.000198	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.41e-06	0.000191	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.38e-06	0.00019	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.36e-06	0.000188	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.33e-06	0.000186	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.3e-06	0.000183	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.11e-06	0.000168	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.1e-06	0.000168	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.03e-06	0.000162	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.02e-06	0.000161	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.78e-06	0.000142	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.24e-06	9.9e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.05e-06	8.39e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.13e-07	6.48e-05	CbGpPWpGaD
